Center opens

November 4, 2010, Thursday |

Print Edition

ELI Lilly has set up a diabetes research center in Shanghai to develop new chemicals targeting the disease and study new therapy for controlling glucose as well as other conditions like cardiac problems and obesity. The pharmaceutical company will recruit 100 researchers who will predominantly come from the Chinese mainland.

Health and Science

About Us
|
Terms of Use
|
RSS
|
Privacy Policy
|
Contact Us
|
Shanghai Call Center: 962288
|
Tip-off hotline: 52920043

沪ICP证：沪ICP备05050403
|
网络视听许可证：0909346
|
广播电视节目制作许可证：沪字第354号
|
增值电信业务经营许可证：沪B2-20120012

Center opens

Email this to your friend